From Wikipedia, the free encyclopedia
(Redirected from
Qlaira)
Combination drug
 | This article needs additional citations for
verification. Please help
improve this article by
adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Estradiol valerate/dienogest" – news · newspapers · books · scholar · JSTOR (April 2019) ( Learn how and when to remove this message) |
 | |
 | |
| Combination of | |
|---|---|
| Estradiol valerate | Estrogen |
| Dienogest | Progestogen |
| Clinical data | |
| Trade names | Lafamme, Natazia, Qlaira |
| Other names | EV/DNG; SH T00658ID; Bay 86-5027; BAY86-5027 |
| AHFS/ Drugs.com | Professional Drug Facts |
| MedlinePlus | a601050 |
| License data | |
|
Pregnancy category | |
|
Routes of administration | By mouth |
| Drug class | Estrogen; Progestogen |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| KEGG | |
Estradiol valerate/dienogest (EV/DNG), sold under the brand names Lafamme, Natazia and Qlaira among others, is a combination product of estradiol valerate, an estrogen, and dienogest, a progestogen, which is used in menopausal hormone therapy in and as a birth control pill to prevent pregnancy in women. It is taken by mouth.
Birth control pills containing EV/DNG are associated with a significantly increased risk of venous thromboembolism. [2] However, they are associated with a significantly lower risk of venous thromboembolism than birth control pills containing ethinylestradiol and a progestin. [2]
See also
- Estradiol valerate/cyproterone acetate
- Estradiol/nomegestrol acetate
- List of combined sex-hormonal preparations
References
- ^ a b c "Dienogest / estradiol (Natazia) Use During Pregnancy". Drugs.com. 27 January 2020. Retrieved 18 March 2020.
- ^ a b Fruzzetti F, Cagnacci A (2018). "Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?". Open Access J Contracept. 9: 75–79. doi: 10.2147/OAJC.S179673. PMC 6239102. PMID 30519125.
External links
- "Dienogest mixture with Estradiol valerate". Drug Information Portal. U.S. National Library of Medicine.
|
Progestogens (and progestins) |
| ||||
|---|---|---|---|---|---|
| Antiprogestogens |
| ||||
| |||||
| ERTooltip Estrogen receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| GPERTooltip G protein-coupled estrogen receptor |
| ||||||
| PRTooltip Progesterone receptor |
| ||||||
|---|---|---|---|---|---|---|---|
|
mPRTooltip Membrane progesterone receptor ( PAQRTooltip Progestin and adipoQ receptor) |
| ||||||
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from April 2019
- All articles needing additional references
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles
From Wikipedia, the free encyclopedia
(Redirected from
Qlaira)
Combination drug
| This article needs additional citations for
verification. Please help
improve this article by
adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Estradiol valerate/dienogest" – news · newspapers · books · scholar · JSTOR (April 2019) ( Learn how and when to remove this message) |
|
| |
|
| |
| Combination of | |
|---|---|
| Estradiol valerate | Estrogen |
| Dienogest | Progestogen |
| Clinical data | |
| Trade names | Lafamme, Natazia, Qlaira |
| Other names | EV/DNG; SH T00658ID; Bay 86-5027; BAY86-5027 |
| AHFS/ Drugs.com | Professional Drug Facts |
| MedlinePlus | a601050 |
| License data | |
|
Pregnancy category | |
|
Routes of administration | By mouth |
| Drug class | Estrogen; Progestogen |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| KEGG | |
Estradiol valerate/dienogest (EV/DNG), sold under the brand names Lafamme, Natazia and Qlaira among others, is a combination product of estradiol valerate, an estrogen, and dienogest, a progestogen, which is used in menopausal hormone therapy in and as a birth control pill to prevent pregnancy in women. It is taken by mouth.
Birth control pills containing EV/DNG are associated with a significantly increased risk of venous thromboembolism. [2] However, they are associated with a significantly lower risk of venous thromboembolism than birth control pills containing ethinylestradiol and a progestin. [2]
See also
- Estradiol valerate/cyproterone acetate
- Estradiol/nomegestrol acetate
- List of combined sex-hormonal preparations
References
- ^ a b c "Dienogest / estradiol (Natazia) Use During Pregnancy". Drugs.com. 27 January 2020. Retrieved 18 March 2020.
- ^ a b Fruzzetti F, Cagnacci A (2018). "Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?". Open Access J Contracept. 9: 75–79. doi: 10.2147/OAJC.S179673. PMC 6239102. PMID 30519125.
External links
- "Dienogest mixture with Estradiol valerate". Drug Information Portal. U.S. National Library of Medicine.
| Estrogens |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Antiestrogens |
| ||||||||
| |||||||||
|
Progestogens (and progestins) |
| ||||
|---|---|---|---|---|---|
| Antiprogestogens |
| ||||
| |||||
| ERTooltip Estrogen receptor |
| ||||||
|---|---|---|---|---|---|---|---|
| GPERTooltip G protein-coupled estrogen receptor |
| ||||||
| PRTooltip Progesterone receptor |
| ||||||
|---|---|---|---|---|---|---|---|
|
mPRTooltip Membrane progesterone receptor ( PAQRTooltip Progestin and adipoQ receptor) |
| ||||||
|
| This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from April 2019
- All articles needing additional references
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles